3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Thoracic aortic surgery in low- and middle-income countries: Time to bridge the gap?

      editorial

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Countries participating in the International Registry of Acute Aortic Dissection. Central Message Thoracic aortic dissections are understudied in low- and lower-middle-income countries. Collaborative efforts such as the International Registry of Acute Aortic Dissection may change this reality. The knowledge surrounding the global epidemiology of thoracic aortic disease is mostly confined to high-income countries, where thoracic aortic aneurysms (TAAs) have an incidence of at least 5.3 per 100,000 people per year and acute thoracic aortic dissections (ATADs) occur in approximately 3 to 4 cases per 100,000 person-years. 1 , 2 The true prevalence of TAAs is likely underestimated because more than 90% of people who live with TAAs remain asymptomatic until dissection or rupture occurs, which may explain why epidemiological estimates of TAAs and ATADs are nearly comparable. Nevertheless, in high-income countries, thoracic aortic surgery already makes up a considerable share of total cardiac surgical volumes: in the United States, 8% of all cardiac surgery procedures involve the thoracic aorta. 3 In low- and middle-income countries (LMICs), detailed epidemiological studies on TAAs and ATADs are lacking, although the overall cardiovascular and aortic disease burdens are increasing: The global morbidity and mortality due to any aortic pathology increased by 67.0% between 1990 and 2019, particularly among LMICs, which experienced an increase of up to 150.6%. 4 These trends are driven by countries’ epidemiological transition away from communicable (infectious) diseases and toward noncommunicable diseases, with an overlapping transition period of a double burden. As life expectancy improves, rates of hypertension and resulting aortic pathology are expected to increase. Between 2000 and 2019, the healthy life expectancy in sub-Saharan Africa increased by 10 years, with overall life expectancy increasing even further, contributing to the rise in noncommunicable diseases and aortic pathology, especially in working-age adults. 5 Unlike high-income countries, LMICs will continue to observe high rates of HIV/AIDS, syphilis, and tuberculosis for many years to come, each of which may contribute to aortic pathology in younger populations. Indeed, evidence suggests the age at ATAAD onset in LMICs is lower compared to high-income countries. 6 Concurrently, traumatic injuries are an important cause of thoracic aortic injury, responsible for 2% to 3% of deaths from road traffic incidents. 7 Despite possessing only 60% of the world’s vehicles, LMICs face more than 90% of deaths due to road traffic injuries worldwide. 8 As a result of these unique challenges, an understanding of the thoracic aortic burden and management in LMICs is crucial to inform health care planning and reduce countries’ aortic morbidity and mortality. The International Registry of Acute Aortic Dissection (IRAD) is an international, multicenter effort focused on acute thoracic aortic dissections and recently celebrated its 25th anniversary. During these 25 years, 97 studies on acute aortic dissections were published. 9 As such, IRAD has been foundational to informing the clinical and surgical management of ATADs, with findings informing guidelines and practice worldwide. IRAD’s growth and scientific contributions are commendable and provide an example for similar initiatives in other areas of cardiothoracic surgery; however, 1 crucial gap remains: IRAD represents 58 aortic surgery centers in 13 countries, of which 56 centers are based in high-income countries (Figure 1). Two centers are based in China and India, and are, respectively, among the world’s highest-volume centers and a private center, thereby not representing the realities of most centers and patients in LMICs. Figure 1 Countries participating in the International Registry of Acute Aortic Dissection. In this article, we summarize access to cardiac surgery in LMICs with a focus on thoracic aortic surgery and briefly summarize the available evidence on scheduled and emergency surgical outcomes for thoracic aortic disease in variable-resource contexts. Herein, we define LMICs according to the World Bank’s Country and Lending Groups classification for the 2024 fiscal year as countries with a gross national income per capita ≤$13,845. We acknowledge that LMICs, home to 6.7 billion people, are heterogeneous in terms of their disease burdens, overall health care capacity, and sociocultural and political systems. Nevertheless, several key challenges, including insufficient cardiac surgical capacity, health coverage, and underrepresentation in cardiac surgical research, are shared, and illustrated through the example of thoracic aortic surgery delivery in Cameroon, an LMIC in sub-Saharan Africa. We conclude by highlighting opportunities to generate contextual evidence for management of thoracic aortic disease in LMICs through IRAD and beyond. Access to Cardiac Surgery in LMICs Access to safe, timely, and affordable cardiac surgical care in LMICs is poor because 6 billion people lack access when needed and more than 100 countries and territories do not have a single cardiac surgeon or cardiac surgical center. 10 , 11 High-income countries rely on 7.15 cardiac surgeons and 2.18 cardiac surgery centers per million population; by contrast, low-income countries have only 0.04 cardiac surgeons and 0.04 centers per million people. 11 , 12 Regionally, sub-Saharan Africa is disproportionately affected: the subcontinent has only 92 cardiac surgery centers to cater for more than 1 billion people. Whereas LMICs face a substantial mismatch between their cardiac surgical needs and capacity, various countries continue to show leadership in terms of surgical volumes (eg, the world’s largest centers are in China and India), procedural costs (eg, centers in India and Vietnam perform cardiac surgery at as little as $1500-$3000), training programs (eg, South Africa, Morocco, and Egypt train cardiac surgeons from across the sub-Saharan African subcontinent), and health coverage (eg, most Latin American countries have comprehensive health coverage, whereas Nepal has introduced a microinsurance scheme to enable children, elderly, and those in poverty to access cardiac surgery for free). 13 , 14 The care provided by surgeons in LMICs is often focused on procedures that minimize resource utilization (eg, less complex congenital heart surgery) and length of stay (eg, need for postoperative intensive care), and are associated with favorable outcomes (eg, lower-risk procedures). This is the result of small overall health budgets and, especially, a lack of prioritization of and investment into cardiac surgical services. 10 Indeed, communicable diseases make up more than half of all global health financing for less than one-third of deaths in LMICs; by contrast, noncommunicable diseases, which notably include cardiovascular disease, receive <2% of funds but account for 74% of all deaths. 15 , 16 This discrepancy between disease burden and political and economic action is sustained by both a focus on smaller, population-level interventions providing potentially faster marginal health gains, despite not necessarily having greater cost-effectiveness, and prevailing myths surrounding care for complex conditions, such as cardiac surgical disease. 17 As such, noncommunicable diseases are on the rise in LMICs without concurrent health systems strengthening efforts to manage this growing burden. Primordial, primary, and secondary preventive efforts are key to mitigate cardiovascular disease burdens, but cannot eradicate cardiovascular disease nor meet the needs of those already living with cardiac surgical disease. Scaling cardiac surgical services requires considerable time for training teams and setting up the necessary infrastructure; waiting to act will only cause greater health system gaps in the future. Thoracic Aortic Surgery in LMICs Reports from LMICs without local cardiac surgical capacity are rare but illustrate the dire situation with patients expiring or requiring costly and traumatizing travel abroad for a glimpse of hope of survival. 18 , 19 In LMICs with local cardiac surgical capacity, thoracic aortic pathology is less frequently managed compared with high-income countries, whether as a result of no diagnosis (eg, death in the community or lack of imaging), no or delayed referral, limited emergency care and surgery capacity, and/or a lack of staffing or resources. 20 Despite these challenges, select centers perform cardiac surgery for thoracic aortic pathology in both scheduled and emergency settings. Although outcomes differ, experienced but lower-volume centers are able to achieve favorable outcomes. 20 For example, several publications from Cameroon illustrate the ability to perform scheduled and emergency thoracic aortic surgery in an LMIC influenced by political instability and conflict.20, 21, 22 There, the local cardiac-aortic surgeon (senior author of this manuscript: Dr Mvondo) was trained abroad and acquired further expertise through visiting team partnerships, now independently performing thoracic aortic procedures in Cameroon. Between 2010 and 2018, 28 patients were operated on for TAAs (N = 18 [64.3%]), ATADs (N = 9 [32.1%]), and a nonsyphilitc pseudoaneurysm (N = 1 [3.6%]). 21 After surgery, the 30-day mortality was 10.7% (5.6% for TAAs; 22.2% for ATADs). More recent findings suggest that, despite delayed referrals and management of patients in the subacute or chronic phase, composite aortic root replacement for type A ATADs (n = 12) with 75% (n = 9) of patients undergoing concomitant aortic arch surgery had an operative mortality of 16.7%, thus comparing favorably to outcomes reported by IRAD. 9 , 20 Lastly, aortic root enlargement with double (mitral and aortic) valve replacements (n = 25) have been successfully performed in young patients (mean age at surgery, 23.3 ± 12.9 years) with predominantly (96%) rheumatic heart disease; the 8% operative mortality rate was higher than that observed in nonrheumatic, high-income country series (<2%). 22 , 23 Patients’ experiences and outcomes could be optimized even further if timely screening, diagnostics, and more experienced and trained professionals across the care continuum were available. Moreover, locoregional registries to track thoracic aortic surgical outcomes in the sub-Saharan subcontinent could provide further insight into the optimal management of local patients to inform quality improvement initiatives. Data from centers in most LMICs, especially low- and lower-middle-income countries, are limited, resulting in the contemporary evidence and clinical guidelines being rooted in populations and high-resourced contexts from (mostly) high-income countries. By contrast, patients managed in LMICs are generally younger, have higher rates of uncontrolled hypertension, and poorer adherence to medical therapy compared with patients in high-income countries. 23 Moreover, aortic consequences of endemic diseases, such as HIV/AIDS, syphilis, and tuberculosis, as well as genetic and biological differences require further study. As such, it is unclear whether existing guidelines may be directly applied in populations unrepresented in the evidence base. It must also be acknowledged that the costs, risks, and needs of thoracic aortic surgery are considerable. In variable-resource contexts, where triage decisions have to be made amidst considerable cardiac surgical waiting lists, noncardiac surgical health agendas, and limited budgets, the decision to perform complex cardiac surgery is potentially contentious. 24 From a purely utilitarian point of view, which seeks to maximize health benefits across the population for a given amount of a good (eg, health budget), thoracic aortic surgery may not be high on the list of priorities. Conversely, egalitarian and prioritarian views may suggest that those worst off should not be neglected and the rule of rescue comes at the forefront; indeed, conditions that are as life-threatening as thoracic aortic pathology would fall under such an umbrella. Regardless of the ethical lens taken, investments into thoracic aortic (and broader cardiac) surgical capacity do not need to come at the cost of other health priorities. LMICs’ spending on health care as part of their health budgets remains considerably below past commitments, whereas global health financing by foreign aid agencies and private organizations should be directed toward overall health systems instead of earmarked to individual disease silos that do not necessarily match local needs. 12 , 15 , 24 The heterogeneous needs and models to establish cardiac centers fall outside the scope of this article but have been described elsewhere. 10 Similarly, thoracic aortic programs in LMICs have different origins, ranging from their introduction through the aortic training of local cardiac surgeons (as observed in Cameroon) to twinning programs between centers. Moving the Center of Thoracic Aortic Research Gravity Evidence from and guidelines for managing populations in high-income countries cannot be assumed to translate directly to the distinct populations and contexts in LMICs, requiring a shift in thoracic aortic research paradigms. Beyond clinical challenges, underreporting of data from LMICs is partially the result of other time pressures and limited research capacity and funding on the ground, as well as the traditional barriers to academic collaborations and publishing. 24 Addressing these hurdles will require proactive support and increased opportunities by existing initiatives to level the playing the field and more comprehensively inform our understanding of ATAD in different populations and regions of the world. Participation in existing database efforts, such as IRAD, can shed light on the current thoracic aortic practices in LMICs. However, barriers to participation must be thoroughly assessed and addressed to avoid skewing of participation toward well-resourced centers that may not be representative of the realities of resources and patient presentations in most cardiac centers in LMICs. Barriers may include a lack of electronic health records, linguistic challenges for data entry, administrative and legal issues, and potential costs surrounding human resources, data infrastructure, or database participation. Addressing these barriers may involve efforts by overarching data infrastructures, organizations, or societies to waive or subsidize costs and provide logistical support to overcome any learning curve. In addition, translations of data input, information, and capacity-building should be provided to move away from an anglophone-dominated research field, which excludes a considerable part of LMICs where English is not frequently spoken (eg, Latin America and francophone African countries). Research efforts may further be supported by clinical efforts to provide virtual continued medical education. In recent years, there has been a surge in online educational platforms and webinars in cardiac surgery, many of which are widely attended across the globe, including by health care professionals from LMICs. 25 For congenital heart surgery, the International Quality Improvement Collaborative has provided a platform for participating congenital heart surgery centers and teams to not only contribute LMIC data to an international outcomes registry but also receive regular training for all team members through recurring webinars. 26 Such an approach engages not merely surgeons but can also ensure research empowerment of all health care professionals engaged in thoracic aortic care and provides further opportunity for clinical team-based training. This may enable aortic team models to be more embedded across the globe and further optimize patient outcomes. In addition, in-person educational opportunities and scholarships, such as those supported by the Thoracic Surgery Foundation, as well as twinning programs between cardiac centers with a focus on thoracic aortic surgery should be further encouraged and supported to scale thoracic aortic surgical care in LMICs. As thoracic aortic surgical efforts and research scale in LMICs, a focus on research equity will be paramount. Evidence from the global surgical literature suggests that authors from high-income countries are disproportionately in first and last authorship positions for research conducted in LMICs, 27 suggesting potential power imbalances or a lack of sponsorship of local authors. Although this may be the result of limited research experience and training, LMIC authors should be supported in developing the research and writing skills necessary to lead their own research efforts. 27 Such research capacity-building may be done in the context of international partnerships with support of high-income country experts, but should, akin to budding cardiac surgical centers, move toward south-south partnerships and, ultimately, full local ownership. Additionally, professional societies play a leading role in raising awareness of the issue of thoracic aortic care in LMICs. For example, annual meetings are increasingly placing global cardiac surgery discussions on their agendas 28 ; in the future, conference organizers may consider thoracic aortic disease as part of these sessions or at dedicated aortic meetings, where such topics remain undiscussed. Furthermore, existing societal efforts, such as the Cardiac Surgery Intersociety Alliance, 29 can better recognize and integrate all aspects of the cardiac surgical care continuum to recognize the systems-wide issues influencing practice, including health policy, health care financing, supply chains, and lifelong care into the community. Lastly, and perhaps most importantly, patients must remain at the center of any global cardiac surgical effort. Among patients with thoracic aortic disease, proper informed consent and shared decision-making practices are essential and must be tailored to patients’ and families’ level of health literacy. In addition, because follow-up after thoracic aortic care is challenging even in high-income countries, telemedicine modalities must be explored. In LMICs, there is a wide availability of smartphones in part due to their use for a variety of purposes, including education and mobile payments; as such, mobile health and telemedicine in LMICs have been successful for a range of cardiovascular prevention and care purposes. 30 Conclusions The efforts of IRAD in the past 25 years are remarkable and have contributed to many lives saved around the world. Geographically expanding IRAD’s efforts to underrepresented countries and populations in the next 25 years can help dissect the realities facing the majority of the world’s population and exponentially increase the influence of IRAD through both clinical evidence and academic and clinical capacity-building. Conflict of Interest Statement The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050

          Summary Background Comprehensive and comparable estimates of health spending in each country are a key input for health policy and planning, and are necessary to support the achievement of national and international health goals. Previous studies have tracked past and projected future health spending until 2040 and shown that, with economic development, countries tend to spend more on health per capita, with a decreasing share of spending from development assistance and out-of-pocket sources. We aimed to characterise the past, present, and predicted future of global health spending, with an emphasis on equity in spending across countries. Methods We estimated domestic health spending for 195 countries and territories from 1995 to 2016, split into three categories—government, out-of-pocket, and prepaid private health spending—and estimated development assistance for health (DAH) from 1990 to 2018. We estimated future scenarios of health spending using an ensemble of linear mixed-effects models with time series specifications to project domestic health spending from 2017 through 2050 and DAH from 2019 through 2050. Data were extracted from a broad set of sources tracking health spending and revenue, and were standardised and converted to inflation-adjusted 2018 US dollars. Incomplete or low-quality data were modelled and uncertainty was estimated, leading to a complete data series of total, government, prepaid private, and out-of-pocket health spending, and DAH. Estimates are reported in 2018 US dollars, 2018 purchasing-power parity-adjusted dollars, and as a percentage of gross domestic product. We used demographic decomposition methods to assess a set of factors associated with changes in government health spending between 1995 and 2016 and to examine evidence to support the theory of the health financing transition. We projected two alternative future scenarios based on higher government health spending to assess the potential ability of governments to generate more resources for health. Findings Between 1995 and 2016, health spending grew at a rate of 4·00% (95% uncertainty interval 3·89–4·12) annually, although it grew slower in per capita terms (2·72% [2·61–2·84]) and increased by less than $1 per capita over this period in 22 of 195 countries. The highest annual growth rates in per capita health spending were observed in upper-middle-income countries (5·55% [5·18–5·95]), mainly due to growth in government health spending, and in lower-middle-income countries (3·71% [3·10–4·34]), mainly from DAH. Health spending globally reached $8·0 trillion (7·8–8·1) in 2016 (comprising 8·6% [8·4–8·7] of the global economy and $10·3 trillion [10·1–10·6] in purchasing-power parity-adjusted dollars), with a per capita spending of US$5252 (5184–5319) in high-income countries, $491 (461–524) in upper-middle-income countries, $81 (74–89) in lower-middle-income countries, and $40 (38–43) in low-income countries. In 2016, 0·4% (0·3–0·4) of health spending globally was in low-income countries, despite these countries comprising 10·0% of the global population. In 2018, the largest proportion of DAH targeted HIV/AIDS ($9·5 billion, 24·3% of total DAH), although spending on other infectious diseases (excluding tuberculosis and malaria) grew fastest from 2010 to 2018 (6·27% per year). The leading sources of DAH were the USA and private philanthropy (excluding corporate donations and the Bill & Melinda Gates Foundation). For the first time, we included estimates of China's contribution to DAH ($644·7 million in 2018). Globally, health spending is projected to increase to $15·0 trillion (14·0–16·0) by 2050 (reaching 9·4% [7·6–11·3] of the global economy and $21·3 trillion [19·8–23·1] in purchasing-power parity-adjusted dollars), but at a lower growth rate of 1·84% (1·68–2·02) annually, and with continuing disparities in spending between countries. In 2050, we estimate that 0·6% (0·6–0·7) of health spending will occur in currently low-income countries, despite these countries comprising an estimated 15·7% of the global population by 2050. The ratio between per capita health spending in high-income and low-income countries was 130·2 (122·9–136·9) in 2016 and is projected to remain at similar levels in 2050 (125·9 [113·7–138·1]). The decomposition analysis identified governments’ increased prioritisation of the health sector and economic development as the strongest factors associated with increases in government health spending globally. Future government health spending scenarios suggest that, with greater prioritisation of the health sector and increased government spending, health spending per capita could more than double, with greater impacts in countries that currently have the lowest levels of government health spending. Interpretation Financing for global health has increased steadily over the past two decades and is projected to continue increasing in the future, although at a slower pace of growth and with persistent disparities in per-capita health spending between countries. Out-of-pocket spending is projected to remain substantial outside of high-income countries. Many low-income countries are expected to remain dependent on development assistance, although with greater government spending, larger investments in health are feasible. In the absence of sustained new investments in health, increasing efficiency in health spending is essential to meet global health targets. Funding Bill & Melinda Gates Foundation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Global cardiac surgery: access to cardiac surgical care around the world

            Cardiovascular disease is the leading cause of death worldwide, responsible for 17.5 million deaths every year, of which 80% occur in low- and middle-income countries. Some 75% of the world does not have access to cardiac surgery when needed because of lack of infrastructure, human resources, and financial coverage. This study aims to map access to cardiac surgery around the world.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Epidemiology of thoracic aortic dissection.

              Thoracic aortic dissection (TAD) is estimated to occur at a rate of 3-4 cases per 100,000 persons per year and is associated with a high mortality. Reported rates are probably underestimates of the true incidence of TAD because of difficulties in diagnosis. The incidence of TAD appears to have been increasing over time. TAD is most common in men and older individuals. Aortic dilatation is a well-established risk factor for TAD but is not a prerequisite; most ascending aortic dissections occur when aortic diameter is <5.5 cm. Although atherosclerosis and typical cardiovascular risk factors, such as hypertension and smoking, are associated with TAD, evidence supporting their direct causal role is lacking. Notably, diabetes mellitus is remarkably uncommon in patients with TAD. Other risk factors for TAD include inflammatory diseases, iatrogenic aortic injury, and drug use. Congenital cardiovascular defects, such as bicuspid aortic valve, and certain genetic syndromes, such as Marfan syndrome, are the genetic factors most commonly associated with TAD. Specific nonsyndromic genetic mutations in families and single nucleotide polymorphisms have also been identified as possible risk factors for TAD.
                Bookmark

                Author and article information

                Contributors
                Journal
                JTCVS Open
                JTCVS Open
                JTCVS Open
                Elsevier
                2666-2736
                20 March 2024
                June 2024
                20 March 2024
                : 19
                : 210-214
                Affiliations
                [a ]Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada
                [b ]Division of Cardiac Surgery, University of Toronto, Toronto, Ontario, Canada
                [c ]Department of Surgery, University of Miami/Jackson Memorial Hospital, Miami, Fla
                [d ]Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Ontario, Canada
                [e ]Division of Cardiac Surgery, Cardiac Center of Shisong, St Elizabeth Catholic General Hospital, Kumbo, Cameroon
                [f ]Department of Surgery, Faculty of Medicine and Pharmaceutical Sciences, Douala, Cameroon
                Author notes
                []Address for reprints: Dominique Vervoort, MD, MPH, MBA, Institute of Health Policy, Management, and Evaluation, University of Toronto, 155 College St, 4th Floor, Toronto, Ontario M5T 3M6, Canada. vervoortdominique@ 123456hotmail.com
                Article
                S2666-2736(24)00060-3
                10.1016/j.xjon.2024.03.002
                11247210
                39015438
                98451ab0-61e7-4888-8318-015e4673e0f4
                © 2024 The Author(s)

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 14 December 2023
                : 5 March 2024
                : 12 March 2024
                Categories
                Adult: Education: Expert Opinion

                cardiac surgery,global surgery,global cardiac surgery,thoracic,aortic surgery,thoracic aortic dissections

                Comments

                Comment on this article